Inkef invests €7.5m in Sapiens

The new equity from Inkef will be used to fund Sapiens' development of the steering brain stimulation implant, used for the treatment of Parkinson's disease.

The investment is an extension of a €16.5m series-A round funding from Edmond de Rothschild Investment Partners, Life Sciences Partners and Wellington Partners in June 2011.

Company
Sapiens is a Dutch medical technology company based in Eindhoven and Munich. It was founded in 2011 as a spinout from Royal Philips Electronics. Sapiens develops treatment solutions for degenerative or functional brain disorders.

People
Founder Frank R Landsberger led the investment on behalf of Inkef and will join Sapiens' board as an adviser. Sjaak Deckers is Sapiens' CEO and co-founder.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Benelux
• Early-stage
• Healthcare
• Netherlands
• Germany
• Wellington Partners
• Life Science Partners